TY  - GEN
AU  - Singla,Nirmish
TI  - Re: Brian I. Rini, Thomas Powles, Michael B. Atkins, et al. Atezolizumab plus Bevacizumab Versus Sunitinib in Patients with Previously Untreated Metastatic Renal Cell Carcinoma (IMmotion151): A Multicentre, Open-label, Phase 3, Randomised Controlled Trial. Lancet 2019;393:2404-15: Putting IMmotion into Motion: Personalizing Frontline Treatment for Metastatic Renal Cell Carcinoma
SN  - 1873-7560
PY  - 2020///1130
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Humans
KW  - Kidney Neoplasms
KW  - Sunitinib
N1  - Publication Type: Letter; Comment
UR  - https://doi.org/10.1016/j.eururo.2019.09.015
ER  -